David Sobell is a Senior Vice President, Portfolio Manager, and a member of the Growth team at Pioneer Investments, which was formerly known as Amundi US, and was acquired by Victory Capital in 2025. David focuses on biotechnology, medical device and healthcare stocks.

Prior to joining Pioneer Investments, David was a Vice President at Hambrecht & Quist Capital Management, where he assisted in the management of a closed-end investment fund. David also worked for Rodman & Renshaw, Inc., as a sell-side equity analyst focusing on the pharmaceutical, drug delivery, and biotechnology industries. Earlier in his career he was a research scientist at the Massachusetts Institute of Technology and at GENE-TRAK Systems, where he worked on developing diagnostic tests for infectious diseases.

David holds a B.A. in Molecular, Cellular and Developmental Biology from the University of Colorado. He also holds a Certificate of Special Studies in Administration and Management from Harvard Extension School, and a Master’s in Management from the M.I.T. Sloan School of Management.